IBB241122C150000
- 0.28
- 0.000.00%
iShares Biotechnology ETF Newsroom
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Catalyst Watch: Robotaxi IPO, OPEC+, Holiday Shopping Data, and Movie Blockbusters
3 'Buy' Stocks and 2 'Hold' Stocks According to Oppenheimer
Viking Therapeutics a New Buy at B Riley on Lead Obesity Asset VK2735
Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Friday Ahead of Business Activity Data
Optimism Over Global Healthcare Sector Rises: Jefferies
Sector Update: Health Care Stocks Rise Pre-Bell Thursday
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Snowflake Stimulates Lagging Market
Gilead Sciences Analyst Ratings
Biogen Analyst Ratings
Muddy Waters CEO expects Trump to make more anti-short sell remarks.
Carson Block, the CEO of the well-known short sell institutions Muddy Waters Capital, predicts that Trump will make more remarks against short sellers during his term in office.
Following the US Secretary of Health, Trump's nomination for the FDA Commissioner seems to be another anti-vaccine advocate.
Makari is a surgeon who opposes overtreatment, advocates for re-evaluating hormone replacement therapy, and reducing the overuse of antibiotics.
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Decoding Amgen's Options Activity: What's the Big Picture?
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
Argenx Analyst Ratings
Exchange-Traded Funds, Equity Futures Higher Pre-Bell as Traders Await Nvidia Earnings
US pharmaceutical stocks plummet, has the market overreacted to Little Kennedy?
Source: Analysis from Wall Street News states that even if Kennedy is confirmed as the Secretary of Health in the usa, he may not be able to "make a big impact". First, there may be divisions within Trump's team; secondly, it is uncertain whether Kennedy has the authority to appoint leaders of departments like the FDA; finally, Trump may appoint individuals with industry backgrounds as FDA commissioners, directing Kennedy's attention to focus on nutrition rather than pharmaceutical approvals. The famous "anti-vaccine pioneer" and advocate for healthy eating, the new government-nominated Secretary of Health Robert Kennedy, is dining with the loyal "fast food enthusiast" Trump, who promotes rapid vaccine development.
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst